Phage Therapy Shows Promise Against Crohn's-Driven E. coli in Mice
Researchers have developed a bacteriophage therapy that neutralizes inflammatory E. coli and boosts corticosteroid efficacy in a mouse model of Crohn's disease.
Read the full articleYou might also wanna read
Crohn’s Disease Phage Therapy Neutralizes Inflammatory E. coli in Mouse Model
Researchers developed a supportive bacteriophage therapy for Crohn’s disease that in a mouse model neutralized a type of E. coli bacteria th
Phages redirect vaccine immunity to attack cancer cells in mouse study
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from v
newscientist.com·12d ago
Un virus que “arranca los dientes” a bacterias dañinas abre una nueva vía contra la inflamación intestinal
Científicos de la Universidad McMaster, en Canadá, usaron al virus para frenar la inflamación crónica en modelos experimentales. Cómo un aná
Phages redirect vaccine immunity to attack cancer cells in mouse study
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from v
newscientist.com·14d agoPhages redirect vaccine immunity to attack cancer cells in mouse study
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from v
newscientist.com·14d ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Meningitis is rare in newborns but often dramatic. For the first time, researchers have developed a preventive approach that stops harmful b
biozentrum.unibas.ch·1mo ago
Milk-derived extracellular vesicles attenuate pre-inflammatory bowel disease via Lactobacillus murinus-mediated TLR2 signaling modulation
Xu et al. show that pre-IBD induced by a combined high-fat diet and antibiotic exposure is alleviated by mEVs through enrichment of L. murin
Comments
Sign in to join the conversation.
No comments yet. Be the first.